STAT3 determines IL-4 signalling outcomes in naïve T cells.

Deimel, Lachlan P; Li, Zheyi; Roy, Sreeja; Ranasinghe, Charani

Deimel, Lachlan P; Li, Zheyi; Roy, Sreeja; Ranasinghe, Charani.

Afiliação

Deimel LP; Molecular Mucosal Vaccine Immunology Group, Department of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, 2601, Australia.
Li Z; Sir William Dunn School of Pathology, Medical Sciences Division, University of Oxford, Oxfordshire, OX1 3RE, UK.
Roy S; Molecular Mucosal Vaccine Immunology Group, Department of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, 2601, Australia.
Ranasinghe C; Molecular Mucosal Vaccine Immunology Group, Department of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, 2601, Australia.

Sci Rep ; 11(1): 10495, 2021 05 18.

Article em En | MEDLINE | ID: mdl-34006897

Assuntos

Interleucina-4/metabolismo; Fator de Transcrição STAT3/fisiologia; Transdução de Sinais; Linfócitos T/metabolismo; Animais; Biomarcadores/metabolismo; Feminino; Camundongos; Camundongos Endogâmicos BALB C; Fosforilação; Receptores de Interleucina-4/metabolismo; Fator de Transcrição STAT6/metabolismo

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T / Transdução de Sinais / Interleucina-4 / Fator de Transcrição STAT3 Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google